Close Menu

NEW YORK ─ Sysmex said Tuesday it has obtained marketing approval in Japan for the use of saliva with BGI Genomics' 2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit.

In March, Kobe, Japan-based Sysmex had obtained marketing approval in the country for the distribution of the kit to detect the RNA of SARS-CoV-2 extracted from upper respiratory tract swabs or lower respiratory tract sputum or bronchoalveolar lavage fluids.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.